As part of the agreement, Astimex is expected to cover distribution of Asonor in Sweden and Finland by the mid of year 2010. Asonor has its presence in Norway and Denmark also.
Asa Lintzen, CEO of Astimex pharma in Sweden, said: “More than 40% of the populations in Sweden and Finland are snoring, and therefore expectations to the market and the famous and well proven product – Asonor is very high.”
Jan Otzen, vice president of TannerMedico, said: “The Asonor Nasal Delivery System lubricates and softens the mucous membrane and tightens the musculature in the throat lightly. This means that breathing is not disturbed in any way, and that your mouth will not be as dry in the morning.”